CET - Theranexus, an innovative biopharmaceutical company in the treatment of rare neurological diseases, today announces the publication of its letter to shareholders. To ...
Genetic differences that contribute to how long a person will live and their risk of Alzheimer's disease have been identified ...
Spinal Devices Market. The global spinal devices market is set to witness remarkable expansion, projected to grow at a CAGR ...
After being referred by their physician, Medicare patients wait an average of 34 days to see a neurologist, accordin ...